Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease

NCT02586909 is registered in ClinicalTrials.gov with Axovant Sciences Ltd. as lead sponsor.

NCT NCT02586909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease
Lead sponsor
Axovant Sciences Ltd.
Phase
Phase 3
Overall status
Terminated
Start date
April 26, 2016
Completion date
March 12, 2018
Enrollment
1,099 (actual)
Sites
169

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease